Missing/wrong data?
Log in to edit
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
scientific article published on 16 May 2013
Author/s
author: Toni Ibrahim, Daniele Santini, Carla Ripamonti
Work details
Publication date
May 16, 2013
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.